Indication
Arteriovenous Malformations
4 clinical trials
2 products
2 drugs
Clinical trial
Pilot Study on the Efficacy of MEK1/MEK2 Inhibitor Trametinib in Patients With Surgical Unruptured Arteriovenous MalformationsStatus: Recruiting, Estimated PCD: 2025-11-01
Product
TrametinibClinical trial
A Modular Open Label, Signal Seeking, Phase II Trial of Targeted Therapies for Patients With Slow-Flow or Fast-Flow Vascular Malformations (TARGET-VM)Status: Not yet recruiting, Estimated PCD: 2026-06-01
Drug
AlpelisibProduct
MirdametinibClinical trial
Genetics of Central Nervous System Arteriovenous Malformations (AVM): Genotype-Phenotype Correlation and Prognostic Impact on Patients With AVMStatus: Recruiting, Estimated PCD: 2024-10-01
Clinical trial
Prospective Evaluation of the Efficacy of Sirolimus (Rapamune®) in the Treatment of Severe Arteriovenous MalformationsStatus: Recruiting, Estimated PCD: 2024-09-01
Drug
rapamycin